Drug Profile
Beclometasone hydrofluoroalkane - DMK Pharmaceuticals
Alternative Names: APC-1000; APC-1000- HFA inhaled oral steroid - DMK Pharmaceuticals; Beclomethasone Dipropionate HFA - DMK PharmaceuticalsLatest Information Update: 13 Sep 2023
Price :
$50
*
At a glance
- Originator Adamis Pharmaceuticals Corporation
- Developer DMK Pharmaceuticals
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Chlorinated steroids; Corticosteroids; Pregnadienetriols; Small molecules; Vascular disorder therapies
- Mechanism of Action Immunosuppressants; Steroid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Suspended Asthma
Most Recent Events
- 07 Sep 2023 Adamis Pharmaceuticals Corporation is now called DMK Pharmaceuticals
- 06 Apr 2021 Suspended - Phase-II for Asthma in USA (Inhalation) before April 2021 (Adamis Pharmaceuticals pipeline, April 2021).
- 17 Jul 2019 Adamis Pharmaceuticals Corporation terminates a phase III trial for Asthma, prior to enrolment (NCT03835871)